Records containing: Wilson Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-06RWE Study of Subjects With Wilson's Disease to Assess Clinical Utility of Measuring Copper Parameters, Including a Novel Non-ceruloplasmin Bound Copper Assay Based on Copper Protein Speciation (NCC-Sp), Standard of Care Clinical and Biochemical Assessments
-
CLINICAL_TRIALS study record update · 2026-04-03Prescreening Study to Identify Potential Participants for a Clinical Study in Wilson Disease (WD) Due to the ATP7B p.H1069Q or p.R778L Mutations
-
CLINICAL_TRIALS study record update · 2026-03-13An Operationally Seamless Phase 1/2/3 Study Consisting of a Safety and Dose-finding Phase 1/2 and Randomized, Open-label, Active-controlled Phase 3 to Evaluate UX701 AAV Gene Therapy in Adults With Wilson Disease
-
CLINICAL_TRIALS study record update · 2026-03-05Monitoring of Therapy in Wilson Disease With Off-Treatment Urinary Copper Excretion (OT-UCE): Comparison With Serum Non-Ceruloplasmin Copper (NCC) Assays
-
CLINICAL_TRIALS study record update · 2026-01-23Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-23Prospective, Single-center, Open-label, Single-arm, Single-dose Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult and Pediatric Patients With Wilson Disease
-
CLINICAL_TRIALS study record update · 2026-01-15Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients Treated With Chelators or Zinc Salts
-
CLINICAL_TRIALS study record update · 2026-01-14Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)
-
CLINICAL_TRIALS study record update · 2025-12-17Oral Health and Wilson's Disease: SOMAWI
-
CLINICAL_TRIALS study record update · 2025-12-10Description of Renal Involvement in Wilson's Disease
-
CLINICAL_TRIALS study record update · 2025-09-15A Multicenter, Open-label, Single-dose, Dose-escalation Phase I/II Clinical Trial Evaluating the Safety, Tolerability, and Efficacy of GC310 Adeno-associated Virus Injection in the Treatment of Patients With Wilson's Disease (WD)
-
CLINICAL_TRIALS study record update · 2025-09-08Evaluation of the Effect of Gene Therapy for Wilson Disease With 64CuCl₂ PET Imaging
-
CLINICAL_TRIALS study record update · 2025-08-12Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect
-
CLINICAL_TRIALS study record update · 2025-07-01Developing a Handheld Anterior Segment Optical Coherence Tomography Device to Assess Kayser Fleischer Rings in Wilson's Disease
-
CLINICAL_TRIALS study record update · 2025-05-22Natural History of Wilson Disease: Registry for Patients With Wilson Disease
-
CLINICAL_TRIALS study record update · 2025-04-04Early Check: A Collaborative Innovation to Facilitate Pre-Symptomatic Clinical Trials in Newborns
-
CLINICAL_TRIALS study record update · 2025-01-15The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease
-
CLINICAL_TRIALS study record update · 2024-12-05Registre Wilson France
-
CLINICAL_TRIALS study record update · 2024-11-21Daily Versus Alternate Day Plasma Exchange in Wilson Disease With Acute Liver Failure in Children: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-10-29An Open-Label, Dose Escalation Study to Evaluate the Tolerability, Safety, and Preliminary Efficacy of MWAV201 in Subjects With Wilson Disease
-
CLINICAL_TRIALS study record update · 2024-10-15A Multicenter, Randomized, Controlled, Open-label, Rater-blinded Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease
-
CLINICAL_TRIALS study record update · 2024-06-20Registro de Enfermedad de Wilson en España
-
CLINICAL_TRIALS study record update · 2024-02-28Inhibitory rTMS Applied on Laryngeal Motor Cortex in Wilson's Disease Patients With Dysarthria
-
CLINICAL_TRIALS study record update · 2023-12-21Evaluation of Cognitive Dysfunction and Psychiatric Comorbidities in Patients With Wilson Disease
-
CLINICAL_TRIALS study record update · 2023-11-07An Open-Label, Two-Single Dose, Two-Period, Parallel Group Study to Assess the Pharmacokinetics and Safety of ALXN1840 in Healthy Adult Japanese and Non-Japanese Subjects